TGFB1 and neoplasm: While many TGF-β treatments aim to discover patient-specific anti-TGF-β therapy, there is growing interest in assessing patients based on their unique TGF-β tumor response and relevant oncogenic pathways in cancer cells (Chen et al., 2021c).